Subscribe
shutterstock_492675739_mdart10
MDart10 / Shutterstock.com
10 May 2022BiotechnologyAlex Baldwin

L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences

Canadian pharmaceutical company  GlycoBioSciences has sued cosmetics giant  L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.
article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.
article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.

More on this story

Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.
article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug